Skip to content

Kidney disease ends here.

example-header

Who we are

Header2

As the largest kidney research charity in the UK, nothing is going to stop us in our urgent mission to end kidney disease. We’re here to be heard, to make a difference, to change the future. This is a disease that ruins and destroys lives. It must be stopped. 

Over the past 60 years, our research has made an impact. But kidney failure is rising, as are the factors contributing to it, such as diabetes and obesity.  

Today, we are more essential than ever. 

Kidney disease affects three million people in the UK, treatments can be gruelling and currently there is no cure. Only research will end this and nobody can do it but us. 

Our ambition

BIGGER, faster and bolder than ever before, and grounded in the hopes and needs of the kidney community. With your help we can protect kidney health and give people the power to live life better with kidney disease.

Our vision is to

free lives from the restrictions, fear, anxiety and life limiting nature of kidney disease.

Our purpose is to...

  • Prevent kidney disease by finding ways to see it coming, and developing interventions to stop it happening.
  • End kidney failure by learning how to spot disease early, how to identify and slow down or stop progression, and how to reverse or repair kidney damage.
  • Transform treatments by making dialysis and transplantation more tolerable and effective, until better alternatives are available.

Our strategy

Bigger. Faster. Bolder. To free lives from kidney disease.
Read our strategy to find out how we will achieve our mission and strategic outcomes.

Leading a transformation in kidney health

Worldwide, around one in 10 people have chronic kidney disease, for which there is no cure. Here in the UK, 20 people develop kidney failure each day, and 64,000 are reliant on dialysis or a transplant to stay alive.

Five people every week die while on the waiting list for a kidney transplant.

Over the past decade some progress has been made in treating kidney disease, but not nearly enough. Kidney disease continues to rise, and history is repeating itself, with successive generations experiencing the same life-limiting health problems and inadequate treatments.

Enough is enough.

On behalf of everyone living with, affected by or at risk of kidney disease, the time has come for change, and we will lead that change. We pledge that over the next ten years we will drive a transformation in kidney health. We’ll do this by working with others to put it on the UK’s agenda. We’ll drive research and see it through so that discoveries quickly translate into life-changing advances. We’ll be responsive; adapting to changes in the landscape that affect kidney health.

Our values:

Ambition

Bravery

Urgency

Passion

Our actions for the next decade:

  • Accelerate discoveries. We’ll fund, prompt and pave the way for a step-change in the research effort, to deliver major advances in our fundamental understanding of kidney health and disease.
  • Make it count. We’ll make sure discoveries are put into practice, so that advances in research rapidly make a difference to people with or at risk of kidney disease.
  • Rally the nation. We will put kidney disease on the UK’s agenda and build a movement to raise awareness and improve kidney health.

To deliver these actions, we need to be at the top of our game. We have a strategic programme to transform the organisation and strive for excellence in everything we do.

Our impact:

Our actions will help to change the future for people living with and at risk of kidney disease, so that by 2030 there will be:

  • Better awareness. More people, particularly those in at risk groups, know how to look after their kidney health.
  • Earlier diagnosis. New ways to detect kidney disease earlier so that people get treatment before irreversible damage is done.
  • New treatments. New ways to slow disease progress so that kidney patients avoid dialysis or a transplant for longer.
  • Better treatments. Technological advances in dialysis, to make it more tolerable and effective.
  • Better kidney transplants. Advances that make transplants last longer, reduce the burden of treatment and monitoring, and improve quality of life.
  • Kinder monitoring. A new and less invasive alternative to having multiple biopsies to monitor kidney disease.
  • Encourage new models of healthcare delivery that improve efficiency and equity of kidney care so everyone in the UK gets the best quality treatment and support they need

Our memberships & affiliations

We are members of...

ABPI Patient Organisation Forum

Association of Medical Research Charities (AMRC)

Scottish Medicines Consortium (SMC) Patient Group Partners

Scottish Medicines Consortium (SMC) Public Involvement Network

All Wales Medicines Strategy Group's Patient and Public Involvement Group

abpi
amrc-logo
SMC
AWMSG
Scroll To Top